000 03675nam a2200397 i 4500
999 _c395874
_d395874
001 395874
003 ES-MaUEC
005 20230118120403.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 211216s2022 sz a o |||| 0|eng d
020 _a9783030851477
024 7 _a10.1007/978-3-030-85147-7
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC280.L9
_b2022 EB
245 0 0 _aClinical Management of Acute Lymphoblastic Leukemia :
_bFrom Bench to Bedside
_cedited by Mark R. Litzow, Elizabeth A. Raetz
250 _a1st edition 2022
264 1 _aCham
_bSpringer International Publishing
_c2022
300 _a1 recurso en línea (XI, 437 páginas)
_b29 ilustraciones, 22 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
505 0 _aTRANSLATIONAL SCIENCE -- Molecular pathways and targets in B cell progenitor acute lymphoblastic leukemia -- Genetic Mechanisms in T-Cell Acute Lymphoblastic Leukemia -- Minimal Residual Disease in Acute Lymphoblastic Leukemia - Techniques and Application -- THERAPEUTICS -- Treatment of Pediatric B and T cell ALL -- Treatment of Adult B and T cell Acute Lymphoblastic Leukemia: An Overview of Current Treatments and Novel Advances -- Acute Lymphoblastic Leukemia in Infants: A distinctive, high risk subtype of childhood ALL -- Treatment of Elderly Patients with Acute Lymphoblastic Leukemia -- Treatment of Childhood Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia -- Treatment of adult Philadelphia chromosome positive ALL -- Treatment of Ph-like ALL -- Prophylaxis and treatment of central nervous system (CNS) ALL -- Late effects of therapy of acute lymphoblastic leukemia -- NEW AND EXISTING MODALITIES OF THERAPY -- Monoclonal Antibody Based Treatment and Other New Agents for B-Lineage ALL -- New Agents for the Treatment of T-Cell ALL -- The development and management of treatment with chimeric-antigen receptor T cell (CAR-T) -- Hematopoietic Stem Cell Transplantation in Adults with Acute Lymphoblastic Leukemia (ALL) -- Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia.
520 _aThis book provides a state-of-the-art overview of acute lymphoblastic leukemia (ALL). The first section of the book presents the translational science behind ALL, reviewing molecular pathways and targets in B- and T-cell ALL, as well as techniques and application of minimal residual disease testing. The second section spotlights ALL management strategies for patients across the spectrum, from infants to the elderly. The final section outlines current and new advances in ALL treatment, including new monoclonal antibodies and allogenic and autologous HSCT. Written by experts in the field, Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside is a valuable resource that will guide patient management, stimulate investigative efforts, and increase understanding of the biologic underpinnings of the disease.
988 _aSpringer_Medicine_2022
650 7 _2embne
_9668066
_aLinfomas
776 0 8 _iPrinted edition:
_z9783030851460
776 0 8 _iPrinted edition:
_z9783030851484
776 0 8 _iPrinted edition:
_z9783030851491
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-85147-7
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b01/2023
_dz
_eb
_zSI